Image_2_Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.TIF (670.6 kB)

Image_2_Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.TIF

Download (670.6 kB)
posted on 2019-09-10, 06:24 authored by Uchini S. Kosgodage, Paul Matewele, Brigitte Awamaria, Igor Kraev, Purva Warde, Giulia Mastroianni, Alistair V. Nunn, Geoffrey W. Guy, Jimmy D. Bell, Jameel M. Inal, Sigrun Lange

Membrane vesicles (MVs) released from bacteria participate in cell communication and host-pathogen interactions. Roles for MVs in antibiotic resistance are gaining increased attention and in this study we investigated if known anti-bacterial effects of cannabidiol (CBD), a phytocannabinoid from Cannabis sativa, could be in part attributed to effects on bacterial MV profile and MV release. We found that CBD is a strong inhibitor of MV release from Gram-negative bacteria (E. coli VCS257), while inhibitory effect on MV release from Gram-positive bacteria (S. aureus subsp. aureus Rosenbach) was negligible. When used in combination with selected antibiotics, CBD significantly increased the bactericidal action of several antibiotics in the Gram-negative bacteria. In addition, CBD increased antibiotic effects of kanamycin in the Gram-positive bacteria, without affecting MV release. CBD furthermore changed protein profiles of MVs released from E. coli after 1 h CBD treatment. Our findings indicate that CBD may pose as a putative adjuvant agent for tailored co-application with selected antibiotics, depending on bacterial species, to increase antibiotic activity, including via MV inhibition, and help reduce antibiotic resistance.